Overview of the 2015 ICS Consensus Conference

 ¹Glickman Urologic and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

 ²Department of Urology, Houston Methodist Hospital, Houston, TX, USA

 ³Division of Urology, Center for Reconstructive Urology and Men's Health, University of Utah, Salt Lake City, UT, USA

 ⁴Department of Urology, Pitié-Salpêtrière Academic Hospital, Assistance Publique-Hôpitaux de Paris, Pierre and Marie Curie Medical School, Paris, France

 ⁵Bristol Urological Institute, University of Bristol, Bristol, UK

 ⁶Department of Urology, Section of Pelvic and Reconstructive Surgery, Mayo Clinic, Rochester, MN, USA

 ⁷Department of Urology, Tulane University Health Sciences Center, New Orleans, LA 70112, USA

 ⁸Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada

 ⁹Department of Urology, Eastern Virginia Medical School, Norfolk, VA, USA

 ¹⁰Department of Urology, University of Texas Southwestern, Dallas, TX, USA

 ¹¹Institute of Urology, Lahey Clinic Medical Center, Tufts University School of Medicine, Burlington, MA 01805, USA

 ¹²Department of Urology, New York University Langone Medical Center, New York, New York, USA

 ¹³Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA

 ¹⁴Division of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA

 ¹⁵Division of Urology, Department of Surgery, University of Texas-Houston Medical School, Houston, TX 77030, USA

The AUS Consensus Group: KW Angermeier (2), TB Boone (3), WO Brant (4), E Chartier-Kastler (5), M Drake (6), DS Elliott (7), WJ Hellstrom (8), S Herschorn (9), KA McCammon (10), AF Morey (11), A Mourtzinos (12), VW Nitti (13), AC Peterson (14), JS Sandhu (15), OL Westney (16), FA Yafi (8).

Dr. David Ginsberg led the peer-review process as the Associate Editor responsible for the paper.

Potential conflicts of interest: Dr. Morey reports other from American Medical Systems, other from Coloplast Corp., outside the submitted work; Dr. Mourtzinos reports other from Boston Scientific, other from Medtronic, other from Allergan, other from Astellas, outside the submitted work; Dr. Elliott has nothing to disclose; Dr. Peterson reports grants from American Medical Systems, grants from Coloplast, during the conduct of the study; grants from American Medical Systems, outside the submitted work; Dr. Chartier-Kastler reports personal fees from AMS, personal fees from uromedica, from null, outside the submitted work; Dr. Yafi has nothing to disclose; Dr. Sandhu reports personal fees from Boston Scientific, outside the submitted work; Dr. Corcos reports grants from Pfizer, grants from Astellas, grants from Allergan, outside the submitted work; Dr. Angermeier reports grants and personal fees from American Medical Systems (now Boston Scientific), outside the submitted work; Dr. Campeau has nothing to disclose; Dr. Drake reports grants, personal fees and non-financial support from Allergan, grants and personal fees from Ferring, grants, personal fees and non-financial support from Astellas, outside the submitted work; Dr. Westney reports grants from American Medical Systems, outside the submitted work; Dr. Aharony has nothing to disclose; Dr. Herschorn reports personal fees from Boston Scientific, during the conduct of the study; grants and personal fees from Astellas, grants and personal fees from Allergan, personal fees from Pfier, personal fees from Merus, personal fees from Lilly, personal fees from Promedon, outside the submitted work; Dr. Boone reports Advisory Board and Speaker—Allergan and Advisory Board and Speaker—Astellas; Dr. Nitti reports Investigator—Allergan, Investigator—Astellas and Investigator—Cook MyoSite; Dr. Brant reports grants and personal fees from Boston Scientific, during the conduct of the study; Dr. Hellstrom reports personal fees from American Medical Systems, during the conduct of the study; personal fees from Abbvie, Allergan, Antares, Astellas, Coloplast, Endo, Pfizer, Repros, Lipocine, other from Coloplast, Endo, NERI, personal fees from Endo, Menarini, other from NIH, Theralogix, outside the submitted work; Dr. Biardeau has nothing to disclose; Dr. McCammon reports other from Honoraria AMS, during the conduct of the study; other from Consultant and Honoraria AMS, outside the submitted work.